We recently published a list of 12 Stocks That Could Split in the Near Future. In this article, we are going to take a look ...

All told, Lilly stock still gained 33% in 2024, outperforming the S&P 500 and Nasdaq Composite. Unfortunately, Lilly ...

Eli Lilly (LLY) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the ...

Most U.S. stocks rose following an encouraging update on inflation, but drops for Eli Lilly and some other influential stocks ...

The S&P 500 added 0.1% on Tuesday, Jan. 14, as tame wholesale inflation data provided a positive signal ahead of Wednesday's ...

Most U.S. stocks rose Tuesday following an encouraging update on inflation, though drops for Eli Lilly and other influential ...

Shares of Eli Lilly were taking a 6.9% hit toward a two-month low in recent trading, enough to make them the S&P 500's biggest decliner. The problem is that the drug giant provided fourth-quarter ...

A solid approach to quality. Our research team assigns Silver ratings to strategies that they have a high conviction will outperform the relevant index, or most peers, over a market cycle on a ...

S&P 500 index funds like VFIAX and SWPPX can be an easy and inexpensive way to round out most investment portfolios. Many, or all, of the products featured on this page are from our advertising ...

The S&P 500 has been red-hot during the past two years. In both 2023 and 2024, the index rose by about 24%. That's well above its long-term average of about 10% per year. Many stocks are trading ...

There is no doubt that S&P 500 (SPX) returns have been fantastic with investors enjoying nearly 30% gains in the last year. It has been a multi-year success story with a roughly 15% CAGR over the ...